Sam Kongsamut
Geen lopende functies
Profiel
Dr. Sam Kongsamut is Executive Director-Pharmacology Division at Neurotrope, Inc.
Dr. Kongsamut was previously employed as a Director-External Innovation by Sanofi.
He received his doctorate degree from The University of Chicago.
Eerdere bekende functies van Sam Kongsamut
| Bedrijven | Functie | Einde |
|---|---|---|
| SANOFI | Corporate Officer/Principal | - |
| NEUROTROPE, INC. | Corporate Officer/Principal | - |
Opleiding van Sam Kongsamut
| The University of Chicago | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| SANOFI | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Neurotrope, Inc.
 Neurotrope, Inc. Pharmaceuticals: MajorHealth Technology Neurotrope, Inc. is a biopharmaceutical company, which engages in the pre-clinical and clinical development of its product candidates. The company focuses on developing a product platform based upon a drug candidate called bryostatin for the treatment of Alzheimer's disease. It also develops bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as Fragile X and Niemann-Pick Type C. The company was founded on January 11, 2011 and is headquartered in New York, NY. | Health Technology |
